i&i Biotech Fund
i&i Biotech Fund (i&i Bio) is a Luxembourg-based venture capital firm that invests in innovative European Life Sciences companies focused on drug discoveries, medical devices, diagnostics, and digital health. The fund was established in cooperation with the biotech incubator i&i Prague and the European Investment Fund. With over €53 million under management, i&i Bio plans to invest in about 20 early-stage companies, supporting transformative Central European technology companies.
Services
Funding
i&i Biotech Fund provides financial support to early-stage Life Sciences companies, focusing on drug discoveries, medical devices, diagnostics, and digital health.
Strategic Guidance and Mentorship
The fund offers strategic guidance and mentorship to its portfolio companies, leveraging its experienced team with backgrounds in private equity, healthcare, and venture capital.
Networking Opportunities
i&i Biotech Fund connects its portfolio companies with a network of investors and potential exit partners, facilitating partnerships and collaborations.
Operational Support
The fund provides operational support to its portfolio companies, helping them navigate the challenges of scaling and commercializing their innovations.
Funding
i&i Biotech Fund provides financial support to early-stage Life Sciences companies, focusing on drug discoveries, medical devices, diagnostics, and digital health.
Strategic Guidance and Mentorship
The fund offers strategic guidance and mentorship to its portfolio companies, leveraging its experienced team with backgrounds in private equity, healthcare, and venture capital.
Networking Opportunities
i&i Biotech Fund connects its portfolio companies with a network of investors and potential exit partners, facilitating partnerships and collaborations.
Operational Support
The fund provides operational support to its portfolio companies, helping them navigate the challenges of scaling and commercializing their innovations.
Portfolio
Developing small-molecule compounds with anticancer properties, focusing on casein kinase inhibitors.
#Drug Discovery
Leader in label-free, multiplexed biosensing, using photonic integrated circuits to simplify biosensing.
#Biosensing Technology
Developing a breakthrough ambulant diagnostic technology for blood coagulation testing, focusing on hemophilia.
#Diagnostics
Developing a diagnostic platform using genetically engineered cells for single cell analysis.
#Diagnostics
Developing cancer treatments based on unique protein conjugates, focusing on metastatic cancer types.
#Cancer Treatment
Designing antibodies for challenging targets using a machine-learning-centred approach.
#Biotechnology
Developing small-molecule compounds with anticancer properties, focusing on casein kinase inhibitors.
#Drug Discovery
Leader in label-free, multiplexed biosensing, using photonic integrated circuits to simplify biosensing.
#Biosensing Technology
Developing a breakthrough ambulant diagnostic technology for blood coagulation testing, focusing on hemophilia.
#Diagnostics
Developing a diagnostic platform using genetically engineered cells for single cell analysis.
#Diagnostics
Developing cancer treatments based on unique protein conjugates, focusing on metastatic cancer types.
#Cancer Treatment
Designing antibodies for challenging targets using a machine-learning-centred approach.
#Biotechnology